You have 9 free searches left this month | for more free features.

City

Moscow (2)

Walnut (2)

Kaluga (1)

Petrozavodsk (1)

Condition

Cancer (1)

HER2-positive Breast Cancer (1)

Overall Status

Active, not recruiting (2)

Phase

Sponsor

OmicsWay Corp. (2)

Collaborator

Kaluga Regional Clinical Oncology Center (1)

Multidisciplinary medical holding SM-Clinic (1)

N.N. Blokhin National Medical Research Center of Oncology (1)

Oncobox Ltd (1)

Oncobox Ltd., Russia (1)

Oncological Clinical Dispensary No. 1 of the Moscow City Health Department (1)

Republican Oncological Dispensary of Karelia Republic, Russia (1)

Vitamed LLC (1)

Vitamed LLC, Russia (1)

Intervention

rna sequencing (2)

transcriptome analysis (2)

chemotherapy (1)

non-target drug (1)

palliative care (1)

target drug with the score above 0,1 (1)

target drug with the score equal or below 0,1 (1)

trastuzumab (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

Industry (2)

Study Type

Observational (2)

Oncobox

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Active, not recruiting

HER2-positive Breast Cancer

RNA sequencing
+3 more

Walnut, California
+3 more

Sep 13, 2021

Cancer Target Therapy Efficacy

Active, not recruiting

Cancer

RNA sequencing
+5 more

Walnut, California
+6 more

Sep 13, 2021